MedTrace Logo

GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL

NCT03861533 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2422

Last updated 2024-08-22

No results posted yet for this study

Summary

This Quality Enhancement Research Initiative (QuERI) is a knowledge translation medical practice activity based on decision making support through feedback to physicians on their management of dyslipidemia in order to achieve guidelines recommended LDL-C levels in high risk patients. Physician interaction has three distinct components:

1. Capture of data as reported by participating physician;
2. Highlight (by providing feedback) where management may be optimized based on guidelines or recommendations;
3. Identify challenges faced by physicians resulting in the care gap..

Conditions

Interventions

OTHER

survey

Cross-Reference

Sponsors & Collaborators

  • Amgen

    collaborator INDUSTRY

  • Dr. Anatoly Langer

    lead OTHER

Principal Investigators

  • Anatoly Langer, MD, M.Sc, FRCP(C,) FACC · Canadian Heart Rersearch Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Kuwait
  • Mexico
  • Saudi Arabia
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03861533 on ClinicalTrials.gov